SSI Diagnostica A/S

SSI Diagnostica Group is a global leader in infectious disease clinical diagnostics, specializing in in vitro diagnostic (IVD) solutions, reagents, antisera, and quality control products. With ~600 employees across Denmark, the United States, and China, the company delivers diagnostic solutions in over 130 countries annually, serving more than 60 million people. Founded as a division of Denmark's Statens Serum Institut in the early 1900s and privatized in 2016, SSI Diagnostica now operates as a unified group comprising five portfolios: SSI Diagnostica, TECHLAB, Beijing Genesee Biotech, CTK Biotech, and Gulf Coast Scientific, combining over 200 years of combined scientific expertise. The company focuses on gastrointestinal, respiratory, bloodborne, and general microbiology diagnostics, providing rapid diagnostic tests, outbreak investigation support, and disease surveillance solutions for reference laboratories, hospitals, and healthcare professionals worldwide.